ReviewFrontiers in endocrinology2025
Fertility preservation: is there a model for gender-dysphoric youth?
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assisted reproductive technologies (ART) and cryobiology advances over the past decades have offered hope to cancer patients who might not otherwise be able to have biological offspring due to the toxic nature of therapies that may lead to subfertility or infertility. Fertility preservation (FP) for youths with gender dysphoria (GD) poses an additional set of complications and obstacles because of the use of medications which block normal pubertal development such as gonadotropin-releasing hormone analogues (GnRHa) and medications which directly alter the genital tract such as cross sex hormones. Here we review the current state of knowledge and ethical concerns with FP focusing on issues when FP is used during adolescent and preadolescent reproductive development in the context of cancer and gender dysphoria treatment. Particularly for youths with GD, very little evidence-based research has been performed and much remains unknown with respect to long term harms to reproductive health and the ultimate success of FP and conception.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.